Literature DB >> 2536991

Sequence analysis of the gene encoding the serotype-specific glycoprotein (VP7) of two new human rotavirus serotypes.

K Y Green1, Y Hoshino, N Ikegami.   

Abstract

Human rotavirus strains 69M and WI61 are distinct from human rotavirus serotypes 1, 2, 3, and 4 and from each other by plaque reduction neutralization and have been proposed as new human rotavirus serotypes (serotype 8 and serotype 9, respectively). The nucleotide sequence of the gene encoding the serotype-specific capsid glycoprotein, VP7, of strains 69M and WI61 was determined. In addition, the sequence of the VP7 gene of strain F45 (serotypically indistinguishable from WI61) was determined. Comparative analyses of the nucleotide and deduced amino acid sequences with those of reference strains from serotypes 1,2,3,4,5, and 6 demonstrated that WI61 and F45 share a high degree of sequence similarity with each other and that strains 69M, WI61, and F45 are distinct from established serotypes 1,2,3,4,5, and 6 in nine defined regions of the VP7 which are variable across rotavirus serotypes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536991     DOI: 10.1016/0042-6822(89)90289-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  Detection and characterization of novel rotavirus strains in the United States.

Authors:  V Gouvea; N Santos
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Application of restriction fragment length polymorphism analysis of VP7-encoding genes: fine comparison of Irish and global rotavirus isolates.

Authors:  F O'Halloran; M Lynch; B Cryan; S Fanning
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Antigenic and genetic characterization of serotype G2 human rotavirus strains from the African continent.

Authors:  N A Page; A D Steele
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

4.  Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001.

Authors:  A R Laird; J R Gentsch; T Nakagomi; O Nakagomi; R I Glass
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

5.  A novel group A rotavirus G serotype: serological and genomic characterization of equine isolate FI23.

Authors:  G F Browning; T A Fitzgerald; R M Chalmers; D R Snodgrass
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

6.  Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.

Authors:  N Kobayashi; K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Predominance of porcine rotavirus G9 in Japanese piglets with diarrhea: close relationship of their VP7 genes with those of recent human G9 strains.

Authors:  Tamara A Teodoroff; Hiroshi Tsunemitsu; Kiyotora Okamoto; Ken Katsuda; Mariko Kohmoto; Kenji Kawashima; Toyoko Nakagomi; Osamu Nakagomi
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  Genetic characterization of a novel, naturally occurring recombinant human G6P[6] rotavirus.

Authors:  Mustafizur Rahman; Karolien De Leener; Truus Goegebuer; Elke Wollants; Ingrid Van der Donck; Lieve Van Hoovels; Marc Van Ranst
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Prevalence of serum neutralizing antibody to serotype 9 rotavirus WI61 in children from South America and central Europe.

Authors:  H Brüssow; H F Clark; J Sidoti
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

10.  Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season.

Authors:  H Fred Clark; Diane A Lawley; Alyssa Schaffer; Janice M Patacsil; Amy E Marcello; Roger I Glass; Vivek Jain; Jon Gentsch
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.